How a buyer's IC actually evaluates an acquisition target.

Why this matters across four audiences

The IC meeting is the same regardless of which side of the table you sit on — sophisticated investment committees apply roughly the same structural framework whether they’re an upper middle-market PE firm acquiring a $30M EBITDA platform, a credit fund underwriting a $50M unitranche, or a strategic buyer integrating a tuck-in. Understanding the working model helps four audiences at once:

• →Operators preparing for sale — see what the buyer's IC will actually test before signing with a banker, so the structural blockers don't surface for the first time during exclusivity
• →Sell-side bankers running mandates — pitch with the IC framework in mind; the bid you don't see comes from the IC question the seller never anticipated
• →Advisors (CEPAs, exit planners, fractional CFOs, M&A advisors) — sequence remediation against the framework the buyer will apply, not the framework that sounds professional
• →Buy-side dealmakers — pressure-test your own committee discipline against the structural questions; if your IC discussion drifts from any of the seven, you may be approving on incomplete evidence

The setting — what an IC meeting actually looks like

A sophisticated IC convenes after the deal team has done two to four weeks of preliminary diligence and (typically) negotiated an LOI or term sheet. The materials in front of the committee include an IC memo (usually 30–60 pages of structured analysis), a financial model, a third-party Quality of Earnings report (when complete), a legal diligence summary, and pre-read appendices on management, market, and operations. The deal team presents for 30–45 minutes; the partners discuss and question for the remainder.

Bain Global Private Equity Reports document the discipline: top-quartile firms apply structured frameworks consistently across deals, while bottom-quartile firms drift toward investment-by-vibes. The structural difference is the framework. The committee that asks the same seven questions on every deal — in the same order, against the same evidence standard — produces measurably better outcomes than the committee that improvises.

The seven questions every IC really asks

The questions don’t always appear in this order; the deal team often pre-empts some in the memo itself. But the underlying structural test is consistent. If any of the seven returns an unsatisfactory answer that can’t be remediated, the deal stalls or gets repriced.

1. Are we underwriting a business or a person?

Key-person dependency is the first question because it’s the structural risk that no amount of post-close work can fully retire. The committee asks: if the owner-operator leaves, does the revenue base survive? Are the customer relationships portable, or are they personal? Are the senior employees on enforceable non-competes? Has the founder built management depth, or are they the management?

The structural test: management transferability. If the founder is the gate to 30–50% of revenue relationships, the IC underwrites a key-person discount that typically shapes the valuation meaningfully — and may require seller-retained equity, deferred consideration, or specific employment commitments structured into the deal. This is one of the most common patterns that quietly reprices initial bids during diligence.

2. Are the financials reconciled, or are we underwriting an estimate?

The Quality of Earnings (QoE) report exists for one reason: the buyer’s IC will not approve on management-prepared financials alone. The QoE provider — typically a top-tier accounting firm or specialized QoE shop — reconciles management’s presented EBITDA against verifiable evidence, surfaces non-recurring items, normalizes working capital, and flags accounting policy choices that don’t survive institutional reporting.

The structural test: AICPA-aligned financial reporting discipline. Reviewed financials (lower evidence grade) are acceptable for many middle-market deals but typically cap the multiple. Audited financials (higher evidence grade) clear the QoE faster and expand the buyer universe. Management-prepared financials with weak reconciliation are the most common pattern that extends diligence beyond 90 days — which itself often kills deals via exclusivity-period expiration.

3. What does customer concentration mean for revenue durability?

Customer concentration is graded against sub-lane-specific thresholds. A 15% top-1 customer concentration looks different in a vertical SaaS business (where 15% may still represent a multi-year subscription with strong renewal mechanics) than in a distribution business (where 15% may represent a master-purchase agreement that can be terminated with 90 days notice). The IC tests not just the concentration percentage but the contract mechanics, renewal patterns, and switching costs that determine revenue durability.

The structural test: revenue durability under stress. The committee asks: if the top-1 customer leaves, what happens to the business? What about the top-3? The top-5? If the answers reveal a business one customer-loss away from severe revenue impairment, the committee underwrites concentration discount — sometimes as a multiple adjustment, sometimes as escrow, sometimes as a representation of customer retention through close.

4. What is the leading-indicator story for the next 18 months?

Buyers don’t pay for trailing performance; they pay for forward expected performance. The IC asks: what evidence supports the underwriting case for the next 18 months? Are the leading indicators (pipeline, recall completion in dental, maintenance plan attach rate in HVAC, lease renewal pricing in real estate, technician retention in service businesses) consistent with the projected revenue trajectory?

The structural test: leading-indicator alignment with case. McKinsey and HBR research on PE value creation consistently emphasizes that operational leading indicators — not financial trailing indicators — drive the actual realized return. The committee that can’t see the leading indicators is underwriting blind; the committee that can see them but doesn’t test for alignment is underwriting trailing performance at a forward multiple. Both are mistakes.

5. What’s the realistic downside, and can the capital structure survive it?

Every IC tests downside. The discipline varies: some committees run formal stress scenarios; others rely on qualitative judgment about “what could go wrong.” The committees that produce top-quartile returns consistently apply structured downside testing — interest rate scenarios, demand shock, customer loss, key-person departure, regulatory change — and test whether the proposed capital structure survives each one.

The structural test: capital structure resilience under stress. The committee asks: can the business service debt under the stress scenarios we’ve modeled? What’s the time-to-consequence on each covenant? What’s the headroom on debt-service coverage if revenue declines 15%? 25%? When the answers reveal a capital structure that breaks under realistic downside, the committee either restructures the deal (less leverage, more equity, different covenant package) or passes.

6. What governance gaps will surface during diligence?

The IC isn’t a board (yet) but it thinks like one. The committee tests whether the business’s governance documentation will support institutional ownership — documented compensation policy, formal vendor approval thresholds, board minutes (if a board exists), succession planning, conflict-of-interest disclosure on related-party transactions, and the basic discipline of running an institutional-quality operation.

The structural test: governance documentation that can support representations and warranties at LOI. The pattern that quietly kills deals at the end of exclusivity: the seller’s legal team can’t make the representations the buyer needs because the documentation doesn’t exist. This usually surfaces in week 8 of diligence. By then, the seller has been off-market for two months, momentum has been lost, and the bid often reprices downward — or the deal fails entirely.

7. What does the exit path look like, and who’s the buyer of last resort?

PE firms aren’t in the long-hold business; they have fund lifecycles. The committee tests: in 5–7 years, who acquires this business, at what valuation, in what condition? Is the exit a strategic acquirer that needs this asset for a specific reason, a financial sponsor running a larger platform, an IPO (rare for middle-market platforms), or a sale to a smaller PE firm at a lower multiple?

The structural test: exit-path realism. The committee that approves a deal without a credible exit path is committing the fund to a position with limited liquidity options. The committee that approves a deal because “there’s always a strategic buyer” without naming the strategic buyers — and testing whether they’d actually acquire this asset — is approving on optimism. The discipline: name the buyers of last resort, in writing, in the IC memo.

What gates approval vs what gets negotiated

Of the seven questions, three typically gate IC approval — meaning an unsatisfactory answer prevents the deal from advancing at all. The other four get negotiated — meaning the deal proceeds with adjustments to price, structure, or conditions.

This is a sub-lane and committee-specific generalization — different ICs gate on different dimensions. What matters for the seller and the banker: knowing which questions are likely to gate vs which will negotiate changes the pre-mandate prep priorities. Resolve the gating questions before going to market; structure around the negotiating questions during the process.

The patterns that quietly reprice deals during diligence

Initial bids reflect what the buyer learned from the CIM, the management meeting, and preliminary diligence. The final price reflects what the buyer learned during the 60–90 days of post-LOI diligence. The gap is where multiple compression lives. The most common patterns:

• →QoE adjustments — non-recurring items presented as recurring; working capital normalizations the seller's CFO didn't model; accounting policy choices that don't survive institutional review. Typical impact: the bid that was '7.5x adjusted EBITDA' becomes '7.5x revised-adjusted EBITDA' where revised-adjusted is materially lower than originally presented.
• →Customer concentration deep-dive — a top-1 customer that looked durable at first turns out to be at-risk; renewal mechanics are weaker than represented; contract end dates are closer than disclosed. Typical impact: deal proceeds with escrow, customer retention rep, and (often) a price adjustment.
• →Key-person discovery — a senior employee who controls a meaningful share of revenue relationships isn't on a non-compete; the founder is more central to operations than the CIM suggested. Typical impact: deferred consideration tied to retention, or material seller-rollover equity to align incentives.
• →Governance documentation gaps — buyer's legal team can't get the representations they need because the documentation doesn't exist; compensation policy is informal; related-party transactions weren't disclosed. Typical impact: reps and warranties insurance premium increases (sometimes uneconomically), or deal restructures with seller-funded escrow.
• →Leading-indicator deterioration — pipeline data shows the next-quarter projection is unsupported; recall completion has dropped since the CIM was prepared; technician retention has slipped. Typical impact: forward EBITDA gets re-projected, multiple stays the same, total consideration drops.

What sellers and their advisors can pre-empt

The structural patterns above are predictable. Sellers and their advisors can pre-empt them by running the buyer’s framework on themselves first — surfacing the named blockers, remediating where possible, and structuring around what can’t be remediated in the available pre-market window.

• →Pre-mandate: run the structural framework on yourself. The IRA grades the same 10 axes the IC will test; the Self-Assessment ($750) produces the operator-attested screening read in 30-45 minutes of intake.
• →If named blockers surface, sequence remediation by gating severity. Resolve gating blockers (financial reconciliation, governance documentation, capital-structure stress) before going to market. Structure around negotiating blockers (key-person, concentration) with explicit pre-emption in the CIM.
• →Engage QoE before signing the mandate, not after the LOI. A pre-signed QoE eliminates the most common multiple-compression pattern (financial reconciliation surprise) and accelerates buyer diligence by 30-60 days.
• →Document governance proactively. Compensation policy, vendor approval thresholds, succession plan, related-party disclosure — all should exist as documents before the banker sends the teaser, not as commitments to produce during diligence.
• →Test capital structure independently. Run downside scenarios that mirror what an institutional acquirer's IC will run. If the existing capital structure can't survive 25% revenue decline, plan for the conversation with the buyer's debt providers.

What this changes about the seller's path

The biggest mistake sellers make is signing a 6% sell-side mandate and discovering the buyer’s structural concerns during a 90-day diligence period. By then, the seller is off-market with momentum lost; the bid often re-prices downward; and the proceeds difference is many multiples of what proactive pre-mandate work would have cost.

The discipline: surface what the IC will see, before the IC sees it. The same engine that produces the buyer’s IC memo grades the seller’s readiness — that’s the structural argument behind Capital Refinery’s same-engine architecture. The seller who runs the IRA before going to market is preparing against the framework the buyer will actually apply, not a framework that sounds professional in a sell-side prep deck.

Sources cited

• →Bain Global Private Equity Report (annual) — top-quartile vs bottom-quartile discipline patterns in IC frameworks → https://www.bain.com/insights/topics/global-private-equity-report/
• →McKinsey on private equity value creation — operational leading indicators vs financial trailing indicators in driving realized returns
• →AICPA Quality of Earnings / Statement on Standards for Attestation Engagements (SSAE 18 and successors) — institutional standards behind the QoE artifact
• →Lovallo & Sibony — 'The Case for Behavioral Strategy' (McKinsey Quarterly, 2010); HBR 'Are You Solving the Right Problem?' (2017) — decision quality in institutional settings
• →Kahneman / Tversky / Tetlock — foundational research on decision-making under uncertainty (referenced in the IC committee framework discipline argument)
• →ILPA Principles — Institutional Limited Partners Association governance standards → https://ilpa.org/principles/
• →Cambridge Associates Private Investment Benchmarks — fund performance dispersion supporting the top-quartile-discipline argument → https://www.cambridgeassociates.com/private-investment-benchmarks/
• →PEI / Private Equity International — industry trade research on IC practices and post-LOI fall-through patterns